Health
Scientists study the sensitivity of SARS-CoV-2 variants to neutralize antibodies – News-Medical.Net
The B.1.1.7 and B.1.351 variants of SARS-CoV-2 were first detected in the UK and South Africa respectively, and have since spread to many other countries.
The B.1.1.7 and B.1.351 variants of SARS-CoV-2 were first detected in the UK and South Africa respectively, and have since spread to many other countries.
Scientists from the Institut Pasteur joined forces with Orléans Regional Hospital, Tours University Hospital, Créteil Intercommunal Hospital, Strasbourg University Hospital and Georges Pompidou European Hospital to study the sensitivity of these two variants to neutralizing antibodies present in the serum samples of people who have been vaccinated…
-
Noosa News20 hours agoPrincess Anne is coming to Australia. Here’s what we know of her plans
-
General11 hours agoDeepfake AI ad featuring WA Premier Roger Cook prompts latest scam warning
-
General10 hours agoCommunity devastated after freight train kills one-year-old girl near Narrabri
-
General8 hours agoPolice allowed neo-Nazi protest outside NSW parliament